UK MHRA Secures EUro 3.6 Million to Expand AI Airlock for Safer Medical AI Innovation
Backed by multi-year government funding, the UK’s first AI medical device regulatory sandbox will scale real-world testing, strengthen oversight and accelerate safe adoption of clinical AI technologies.
Digitalization | 09/04/2026 | By News Bureau | 273
Transgene, NEC Bio B.V. Sign Licensing Deal to Advance AI-Driven Cancer Vaccine
Transgene's Agreement wirh NEC Bio B.V. to accelerate development of TG4050, a personalised neoantigen immunotherapy for head and neck cancer, combining viral vector technology with AI-based prediction.
Digitalization | 07/04/2026 | By News Bureau | 162
Eli Lilly Eyes USD 2 Billion AI Drug Discovery Deal with Insilico Medicine
Eli Lilly is set to enter into a deal worth over USD 2 billion with Hong Kong-based Insilico Medicine to accelerate drug discovery using artificial intelligence, signaling a major push toward AI-driven pharmaceutical innovation.
Digitalization | 30/03/2026 | By Darshana | 213
Discovery Life Sciences and Mindpeak Partner for AI Cancer Biomarker Testing
Discovery Life Sciences and Mindpeak partner to bring AI-driven cancer biomarker testing in global clinical trials, aiming to reduce variability in biomarker interpretation and improve accuracy in drug development.
Digitalization | 25/03/2026 | By News Bureau | 169
Insilico Medicine Launches PandaClaw AI Platform for Drug Discovery
Insilico Medicine launches PandaClaw AI platform to accelerate drug discovery, enabling real-time analysis, target identification and disease hypothesis generation through an intuitive natural language interface.
Digitalization | 24/03/2026 | By News Bureau | 175
Earendil Labs Raises USD 787 Million to Scale AI-Driven Biologics Discovery
Earendil Labs will use its USD 787 million financing to scale its Artificial Intelligence (AI)-driven R&D platform, expand inter-disciplinary teams and advance a pipeline of antibody and biologics programmes targeting serious diseases.
Digitalization | 21/03/2026 | By News Bureau | 333
Fauna Bio Announces Target Designation Milestone in Obesity Discovery Collaboration
Fauna Bio has achieved a target designation milestone in its obesity discovery collaboration, advancing a novel target identified through its Convergence AI platform.
Digitalization | 20/03/2026 | By News Bureau | 146
Dalriada Drug Discovery and Topos Bio collaborate to accelerate drug discovery for intrinsically disordered proteins using AI, mass spectrometry and proteomics to improve experimental validation and therapeutic development.
Digitalization | 18/03/2026 | By News Bureau | 202
Agilisium Invests INR 50 Crore to Accelerate AI Adoption in Life Sciences
Agilisium’s new forward deployment Artificial Intelligence (AI) model embeds specialised experts within life sciences organisations, enabling faster and practical adoption of AI by bridging the gap between innovation and real-world execution.
Digitalization | 18/03/2026 | By Akanki | 271
GenomOncology Partners with WeTrials to Accelerate Clinical Trial Access for CNS Cancer Patients
GenomOncology and WeTrials collaborate to streamline clinical trial enrollment for Central Nervous System Cancer patients, integrating genomic reports with AI-driven patient engagement tools through expanded partnership with Belay Diagnostics.
Digitalization | 11/03/2026 | By News Bureau | 153
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy